Chronic low back pain is one of the leading causes of adult disability globally. Currently there are no therapeutic options that target the commonest pathophysiology of back pain which is intervertebral disc degeneration. Intradiscal therapeutics aim to treat some aspects of the pathological disease processes, by regenerating or assisting biophysical characteristics of the intervertebral disc. Intradiscal therapies include biological therapy, cell-free implantation, and anti-inflammatory agents and research conducted into these areas will in time elucidate an effective intradiscal therapeutic for disc degeneration. This chapter reviews the horizon of this exciting area of development.